PubRank

Anders Hartmann

Author PubWeight™ 97.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 2003 4.19
2 Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus. Transplantation 2015 2.00
3 Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 2009 1.79
4 Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis 2009 1.64
5 Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 2004 1.57
6 Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Nephrol Dial Transplant 2004 1.46
7 Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. Nephrol Dial Transplant 2014 1.45
8 The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man. Nephrol Dial Transplant 2007 1.43
9 Diagnosing PTDM. Transplantation 2002 1.37
10 The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2002 1.36
11 Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation 2008 1.34
12 Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004 1.13
13 Assessment of renal allograft fibrosis by acoustic radiation force impulse quantification--a pilot study. Transpl Int 2010 1.10
14 Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation 2009 1.09
15 Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population. Nephrol Dial Transplant 2011 1.08
16 Acute renal failure early after heart transplantation: risk factors and clinical consequences. Clin Transplant 2010 1.07
17 The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation 2011 1.07
18 CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients. Pharmacogenet Genomics 2008 1.07
19 Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antivir Ther 2009 1.05
20 Benefit of kidney transplantation beyond 70 years of age. Nephrol Dial Transplant 2009 1.02
21 Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study. BMC Endocr Disord 2010 1.01
22 Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy. Clin J Am Soc Nephrol 2010 1.01
23 A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 2003 1.01
24 Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin. Nephrol Dial Transplant 2005 1.00
25 Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation 2011 1.00
26 Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study. Ann Rheum Dis 2010 0.97
27 Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int 2005 0.97
28 Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. J Am Soc Nephrol 2006 0.95
29 The risk of living kidney donation. Nephrol Dial Transplant 2003 0.94
30 Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol Dial Transplant 2005 0.92
31 Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade. Transplantation 2007 0.92
32 Early versus late acute antibody-mediated rejection in renal transplant recipients. Transplantation 2013 0.89
33 Long-term clinical outcome of paediatric kidneys transplanted to adults. Nephrol Dial Transplant 2008 0.88
34 Kidney transplantation in the elderly--the Norwegian experience. Nephrol Dial Transplant 2007 0.88
35 Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients. Transplantation 2008 0.88
36 Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. Kidney Int 2004 0.87
37 The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant 2002 0.87
38 Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy. Clin J Am Soc Nephrol 2006 0.86
39 Determinants of short-term changes in body composition following renal transplantation. Scand J Urol Nephrol 2009 0.86
40 Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation. Transpl Int 2013 0.86
41 Determinants of insulin secretion after renal transplantation. Metabolism 2003 0.85
42 Non-invasive assessment of renal allograft fibrosis by dynamic sonographic tissue perfusion measurement. Acta Radiol 2011 0.84
43 New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection. Curr Diabetes Rev 2005 0.84
44 [Methanol poisoning in Norway 2002]. Tidsskr Nor Laegeforen 2004 0.84
45 A prospective study on size and function of paediatric kidneys (<10 years) transplanted to adults. Nephrol Dial Transplant 2007 0.84
46 Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria. Nephrol Dial Transplant 2010 0.84
47 The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival. Clin Transplant 2013 0.83
48 High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients. Transplantation 2015 0.83
49 Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients. Transplantation 2015 0.82
50 Glucose tolerance before and after renal transplantation. Nephrol Dial Transplant 2009 0.82
51 Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study. Transplant Res 2013 0.82
52 Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses. Transplantation 2012 0.82
53 Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium. Nephrol Dial Transplant 2011 0.82
54 Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin Transplant 2014 0.82
55 Experience from an active preemptive kidney transplantation program--809 cases revisited. Transplantation 2009 0.82
56 Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients. Transplantation 2006 0.81
57 Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients. Clin Transplant 2013 0.81
58 Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation. Nephrol Dial Transplant 2008 0.81
59 Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients. Transplant Res 2012 0.81
60 Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection. Clin Transplant 2003 0.81
61 Risk factors for mortality in diabetic nephropathy patients accepted for transplantation. Transplantation 2007 0.81
62 Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation. Nephrol Dial Transplant 2008 0.81
63 Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk. Clin Transplant 2007 0.81
64 Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function. Transplantation 2005 0.81
65 Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation. J Heart Lung Transplant 2010 0.81
66 Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation. Arthritis Rheum 2011 0.80
67 A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients. Clin Pharmacokinet 2009 0.80
68 Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patients. Clin Transplant 2014 0.80
69 Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation. Clin Transplant 2008 0.80
70 The kidney transplantation program in Norway since 2000. Clin Transpl 2011 0.80
71 A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8). Blood Purif 2011 0.79
72 Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial. Clin Transplant 2013 0.79
73 A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients. Transplantation 2013 0.79
74 Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients. Transplantation 2009 0.79
75 Hypertension after kidney transplantation: are treatment guidelines emerging? Nephrol Dial Transplant 2002 0.79
76 AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism. Ther Drug Monit 2008 0.79
77 Endothelial dysfunction is associated with graft loss in renal transplant recipients. Transplantation 2013 0.79
78 Impaired glucose homeostasis in renal transplant recipients receiving basiliximab. Nephrol Dial Transplant 2009 0.79
79 No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus. Nephrol Dial Transplant 2011 0.79
80 Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients. Expert Opin Pharmacother 2010 0.78
81 Predictors of health-related quality of life in hypertensive recipients following renal transplantation. Clin Transplant 2005 0.78
82 Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma. PLoS One 2013 0.78
83 Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy. J Clin Virol 2012 0.78
84 Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome. Transplantation 2012 0.78
85 Multiple risk assessment of cardiovascular surgery in chronic renal failure patients. Ann Thorac Surg 2005 0.78
86 Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients. Clin Transplant 2007 0.77
87 Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation. Scand J Clin Lab Invest 2009 0.77
88 Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial. BMC Nephrol 2012 0.77
89 Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot study. Ther Drug Monit 2010 0.77
90 Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study. Nephrol Dial Transplant 2003 0.77
91 Development of renal structural lesions in type-1 diabetic patients with microalbuminuria. Observations by light microscopy in 8-year follow-up biopsies. Virchows Arch 2002 0.76
92 Prevention and management of transplant-associated diabetes. Expert Opin Pharmacother 2011 0.76
93 Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation. Clin Transplant 2003 0.76
94 Life situation and quality of life in young adult kidney transplant recipients. Nephrol Dial Transplant 2008 0.76
95 Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation - a population based study. Clin Transplant 2010 0.76
96 Prevalence and risk factors for coronary artery calcification following kidney transplantation for systemic lupus erythematosus. Rheumatology (Oxford) 2011 0.76
97 Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients. Eur J Clin Pharmacol 2005 0.76
98 Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients. Transplantation 2015 0.76
99 Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients. Clin Transplant 2011 0.76
100 Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients. Clin J Am Soc Nephrol 2012 0.76
101 In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone. Diabetologia 2014 0.75
102 Immunotherapy for invasive fungal infections in transplant patients: back to the future? Am J Transplant 2010 0.75
103 Diagnosing PTDM. Transplantation 2003 0.75
104 Ghrelin, atherosclerosis, and glucose: GAG or causal relationships? Transplantation 2007 0.75
105 Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation? Transplantation 2016 0.75
106 Response to Montori et al. Post-transplantation diabetes (PTD), risk factors for its development, prognostic implications, and optimal management of the disease. Diabetes Care 2002 0.75
107 The Authors' Reply. Transplantation 2017 0.75
108 Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival. Transplantation 2017 0.75
109 [Lupus-nephritis--diagnosis and treatment]. Tidsskr Nor Laegeforen 2010 0.75
110 Uric acid and clinical correlates of endothelial function in kidney transplant recipients. Clin Transplant 2014 0.75
111 Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients. Transplantation 2017 0.75
112 Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population. Nephrol Dial Transplant 2016 0.75
113 [Is current practice concerning living donors in kidney transplantations acceptable?]. Tidsskr Nor Laegeforen 2003 0.75
114 Role of prednisolone pharmacokinetics in postchallenge glycemia after renal transplantation. Ther Drug Monit 2008 0.75
115 Increased peak systolic velocity in the renal artery of paediatric kidneys transplanted to adult recipients. Nephrol Dial Transplant 2008 0.75
116 Association between insulin resistance and endothelial dysfunction in renal transplant recipients. Clin Transplant 2006 0.75
117 Long-term diabetes complications after pancreas transplantation. Curr Opin Organ Transplant 2017 0.75
118 Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation. Transplantation 2017 0.75
119 Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients. Transpl Int 2006 0.75
120 Predictors of anemia in patients on hemodialysis. Hemodial Int 2009 0.75
121 Renal transplantation is also an option for patients over 70. Tidsskr Nor Laegeforen 2011 0.75
122 Low molecular weight heparins as thromboprophylaxis in patients undergoing hemodialysis/hemofiltration or continuous renal replacement therapies. Eur J Med Res 2004 0.75
123 Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation. Clin Transplant 2009 0.75
124 High tacrolimus clearance is a risk factor for acute rejection in the early phase after renal transplantation. Transplantation 2017 0.75